Quick Heal Technologies Ltd is Rated Strong Sell

1 hour ago
share
Share Via
Quick Heal Technologies Ltd is rated Strong Sell by MarketsMojo. This rating was last updated on 22 May 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 01 July 2026, providing investors with the latest insights into its performance and prospects.
Quick Heal Technologies Ltd is Rated Strong Sell

Understanding the Current Rating

The Strong Sell rating assigned to Quick Heal Technologies Ltd indicates a cautious stance for investors, suggesting that the stock is expected to underperform relative to the broader market and its peers. This recommendation is grounded in a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment appeal and risk profile.

Quality Assessment

As of 01 July 2026, Quick Heal Technologies Ltd exhibits a below-average quality grade. The company’s long-term fundamental strength is weak, primarily due to sustained operating losses. Its average Return on Equity (ROE) stands at a modest 4.29%, signalling limited profitability relative to shareholders’ funds. This low ROE reflects challenges in generating efficient returns on invested capital, which is a critical measure of management effectiveness and business sustainability.

Moreover, the company reported negative results in the March 2026 quarter, following flat performance in December 2025. Profit Before Tax (PBT) excluding other income declined sharply to a loss of ₹33.42 crores, a fall of 174.61%, while Profit After Tax (PAT) plunged by 513.5% to a loss of ₹19.94 crores. The Return on Capital Employed (ROCE) for the half-year period was also negative at -4.68%, underscoring the company’s struggles to generate returns above its cost of capital.

Valuation Considerations

The valuation grade for Quick Heal Technologies Ltd is classified as risky. The company’s negative Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) of ₹-29.37 crores highlights ongoing operational challenges. Over the past year, the stock has delivered a return of -56.42%, significantly underperforming the broader market benchmark, the BSE500, which declined by only -2.55% during the same period.

Such a steep decline in stock price, coupled with deteriorating profitability—profits have fallen by 316.9% over the last year—indicates that the market is pricing in considerable risk. The current valuation does not offer comfort to investors, as it suggests the stock is trading at levels that reflect heightened uncertainty and potential downside.

Financial Trend Analysis

The financial trend for Quick Heal Technologies Ltd remains negative. The company’s recent quarterly results reveal a continuation of losses and declining profitability metrics. The operating losses and negative cash flow trends raise concerns about the company’s ability to sustain operations without significant strategic changes or capital infusion.

Institutional investor participation has also waned, with a decrease of 0.86% in their stake over the previous quarter, leaving institutional holdings at a mere 1.89%. This reduction in institutional interest is notable, as these investors typically possess superior analytical resources and tend to reduce exposure to companies with deteriorating fundamentals.

Technical Outlook

From a technical perspective, the stock is mildly bearish. While there was a short-term recovery with a 3-month gain of 21.38%, this was overshadowed by significant losses over six months (-34.64%) and the year-to-date period (-34.60%). The one-day gain of 0.93% on 01 July 2026 offers limited relief in the context of the broader downtrend.

The technical grade reflects cautious sentiment among traders and investors, with price action indicating persistent selling pressure and limited momentum to reverse the negative trend. This technical backdrop supports the overall Strong Sell rating, signalling that the stock is unlikely to experience a sustained rally in the near term.

Comparative Market Performance

Quick Heal Technologies Ltd’s underperformance relative to the market is stark. While the BSE500 index has declined modestly by -2.55% over the past year, Quick Heal’s stock has fallen by over half its value, delivering a -56.42% return. This divergence highlights the company’s specific challenges and the market’s lack of confidence in its near-term prospects.

Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.

  • - Market-beating performance
  • - Committee-backed winner
  • - Aluminium & Aluminium Products standout

Read the Winning Analysis →

What the Strong Sell Rating Means for Investors

For investors, the Strong Sell rating on Quick Heal Technologies Ltd serves as a cautionary signal. It suggests that the stock currently carries elevated risks due to weak fundamentals, unfavourable valuation, deteriorating financial trends, and bearish technical indicators. Investors should carefully consider these factors before initiating or maintaining positions in the stock.

While some investors may view the depressed valuation as an opportunity, the persistent operating losses and negative returns highlight the need for prudence. The company’s financial health and market performance indicate that recovery may be protracted and uncertain, making it a less attractive option for risk-averse investors or those seeking stable returns.

Summary

In summary, Quick Heal Technologies Ltd’s current Strong Sell rating by MarketsMOJO, updated on 22 May 2026, reflects a comprehensive evaluation of its present-day financial and market position as of 01 July 2026. The company faces significant challenges across quality, valuation, financial trend, and technical dimensions, which collectively justify a cautious investment stance.

Investors are advised to monitor the company’s quarterly results and market developments closely, as any improvement in profitability, cash flow, or institutional interest could alter the outlook. Until then, the Strong Sell rating underscores the importance of risk management and careful portfolio allocation when considering this stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News